Literature DB >> 16873987

Fulminant type 1 diabetes mellitus.

Akihisa Imagawa1, Toshiaki Hanafusa.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 16873987     DOI： 10.1507/endocrj.kr-72

Source DB:  PubMed          Journal:  Endocr J        ISSN： 0918-8959            Impact factor:   2.349


× No keyword cloud information.
  8 in total

Review 1.  The role of immunomodulation therapy in autoimmune diabetes.

Authors:  Johnny Ludvigsson
Journal:  J Diabetes Sci Technol       Date:  2009-03-01

Review 2.  Diabetes mellitus: The epidemic of the century.

Authors:  Akram T Kharroubi; Hisham M Darwish
Journal:  World J Diabetes       Date:  2015-06-25

3.  Clinical characteristics of fulminant type 1 diabetes associated with pregnancy in China.

Authors:  Lan Liu; Jiping Mao; Zeyuan Lu; Xiaojie Yan; Xiaosu Bai; Yiyi Ye; Gang Zou
Journal:  Endocrine       Date:  2011-06-22       Impact factor: 3.633

4.  Fulminant type 1 diabetes mellitus observed in insulin receptor substrate 2 deficient mice.

Authors:  T Arai; H Hashimoto; K Kawai; A Mori; Y Ohnishi; K Hioki; M Ito; M Saito; Y Ueyama; M Ohsugi; R Suzuki; N Kubota; T Yamauchi; K Tobe; T Kadowaki; K Kosaka
Journal:  Clin Exp Med       Date:  2008-07-11       Impact factor: 3.984

5.  New-onset fulminant type 1 diabetes after severe acute respiratory syndrome coronavirus 2 vaccination: A case report.

Authors:  Keyaki Sasaki; Tomoaki Morioka; Natsumi Okada; Yuka Natsuki; Yoshinori Kakutani; Akinobu Ochi; Yuko Yamazaki; Tetsuo Shoji; Takashi Ohmura; Masanori Emoto
Journal:  J Diabetes Investig       Date:  2022-02-25       Impact factor: 3.681

6.  Autoimmune pancreatitis: the emerging role of serologic biomarkers.

Authors:  John W Wiley; Massimo Pietropaolo
Journal:  Diabetes       Date:  2009-03       Impact factor: 9.461

7.  Fulminant type 1 diabetes in Korea: high prevalence among patients with adult-onset type 1 diabetes.

Authors:  Y M Cho; J T Kim; K S Ko; B K Koo; S W Yang; M H Park; H K Lee; K S Park
Journal:  Diabetologia       Date:  2007-08-28       Impact factor: 10.122

8.  Estimation of Duration of Symptoms in Fulminant Type 1 Diabetes Mellitus Using HbA1c or Glycated Albumin.

Authors:  Akitsu Kawabe; Takashi Seta; Sumie Fujii; Masayo Yamada; Shogo Oki; Jun Murai; Hiroshi Saito; Masafumi Koga
Journal:  Jpn Clin Med       Date:  2012-05-21
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.